ÈÈÃű¬ÁÏ

Committee on Advancing Excellence and Population Health

Committee Roster

Chair
Alison R. Walker, MD, MBA, MPH  ('26)

Appointed Members
Staci D. Arnold, MD, MBA, MPH  ('25)
Brandon Blue, MD  ('25)
Gregory Sampang Calip, PhD, PharmD, MPH  ('26)
Blachy J. Davila Saldana, MD  ('25)
Marcos de Lima, MD  ('25)
Srinivas S. Devarakonda, MD  ('26)
Warren Fingrut, MD, MPH  ('26)
Beatrice Gee, MD  ('27)
Kalpna Gupta, PhD  ('25)
Monique Hartley-Brown, MD  ('25)
Frederick Lansigan, MD  ('26)
Rakesh Mehta, MD  ('27)
Jonathan Moreira, MD  ('25)
Oreofe O. Odejide, MD, MPH  ('27)
Kerice A. Pinkney, MD  ('27)
Rayne H. Rouce, MD  ('26)
Melody Smith, MD, MS  ('26)
Noha Soror, MD, MSc  ('28)
Georgia B. Vogelsang, MD  ('25)
Rahma Warsame, MD  ('28)
David S. Wilkes, MD  ('27)

Ex Officio Members
Belinda Avalos, MD  ('25)  - President
Cynthia E. Dunbar, MD  ('27)  - Vice President
Robert Negrin, MD  ('26)  - President-Elect

Liaisons
Glaivy Batsuli, MD  - Co-Chair, Women in Hematology Working Group
Lisa Hicks, MD, MSc  ('26)  - Health Equity Task Force Co-Chair
Abner Louissaint, MD, PhD  ('25)  - Publications Committee
Kellie Machlus, PhD  ('25)  - Nominating Committee
Ruben A. Mesa, MD  ('26)  - Health Equity Task Force Co-Chair
Arturo Molina, MD, MS  - ASH Representative to AMFDP NAC
Margo Renee Rollins, MD  ('27)  - Chair, HIP Programs Subcommittee
Bethany Samuelson Bannow, MD, PhD  - Co-Chair, Women in Hematology Working Group

Staff Liaison
±Ê²¹³Ù°ù¾±³¦¾±²¹Ìý¹ó°ù³Ü²õ³Ù²¹³¦±ð

Committee Mandate

The Committee on Advancing Excellence and Population Health is responsible for leading efforts to achieve the commitments delineated in the ASH statement on expansion and inclusion in hematology.

The work of the committee includes:

• Establishing the vision and strategy for achieving ASH’s excellence and inclusion priorities.
• Strengthening ASH’s awareness and understanding of the issues that drive the need for a dedicated focus on inclusive excellence and ensuring that ASH remains on the forefront of this work.
• Understanding and disseminating relevant best practices throughout ASH committees and programs.
• Identifying opportunities for accelerating inclusive excellence within hematology and peer networks.
• Measuring the impact of on-going efforts.

The committee structure includes at least two ASH members who have a PhD designation (to ensure that the interests of this constituency are represented) as well as the following liaison members:

• Nominating Committee member (term congruent to service on parent committee)
• Publications Committee member (term congruent to service on parent committee)
• HIP Programs Subcommittee Chair (under purview of committee)
• Treating Fairly Task Force Co-Chairs (under auspices of committee)
• Women in Hematology Co-Chairs Working Group

Members of the committee are required to attend two meetings per year: one in the spring and one in the fall. They are further expected to directly engage in individual and small group projects at the direction of the chair. Finally, they are expected, but not required, to participate in at least one HIP Programs Study Section meeting during their term.

The chair of the committee serves as a liaison member of the Program Committee and the Media Experts Subcommittee and is expected to attend the meetings of those committees. Members of the committee serves as liaison members of the Awards Committee; Committee on Government Affairs; Committee on Practice; Committee on Quality; Committee on Scientific Affairs; Committee on Training; ASH Ambassador Oversight Subcommittee; Hematology International Medical Graduates Working Group; and Task Force on PhD Careers in Hematology and are expected to attend the meetings of those committees.

The committee makes funding recommendations to the ASH Executive Committee which makes funding decisions.

...